MDMA impairs response to water intake in healthy volunteers

BioRxiv : the Preprint Server for Biology
Matthew J BaggottJohn E Mendelson

Abstract

Hyponatremia is a serious complication of 3,4-methylenedioxymethamphetamine (MDMA) use. We investigated potential mechanisms in two double-blind, placebo- controlled studies. In study 1, healthy drug-experienced volunteers received MDMA or placebo alone and in combination with the alpha-1 adrenergic inverse agonist prazosin, used as a positive control to release antidiuretic hormone (ADH). In study 2, volunteers received MDMA or placebo followed by standardized water intake. MDMA lowered serum sodium, but did not increase ADH or copeptin, although the control prazosin did increase ADH. Water loading reduced serum sodium more after MDMA than after placebo. There was a trend for women to have lower baseline serum sodium than men, but there were no significant interactions with drug condition. Combining studies, MDMA potentiated the ability of water to lower serum sodium. Thus, while MDMA lowers serum sodium and potentiates effects of water intake on serum sodium, ADH may not be the mechanism of these changes.

Related Concepts

Argipressin
Complication
Double-Blind Method
Human Volunteers
Hyponatremia
Male Population Group
Placebos
Prazosin
Sodium
Woman

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

Advances in Pharmacological Sciences
Matthew J BaggottJohn E Mendelson
Horumon to rinsho. Clinical endocrinology
S Urakabe, D Shirai
Medizinische Monatsschrift
H Wagner, P Schmidt-Wiederkehr
© 2021 Meta ULC. All rights reserved